70-year-old with recurrent ovarian cancer

After several therapies and relapses, a 70-year-old female patient with advanced ovarian cancer experienced renewed progression. The use of Molecular Health Guide (MH Guide) provided the molecular tumor board with comprehensive insights and individual therapeutic recommendations.

Download Whitepaper (PDF)

GDPR Cookie Consent with Real Cookie Banner